ADVERTISEMENT
Onderstepoort Biological Products (OBP)
Financial Information
All Financial Values: R'000 | 2023/24 | 2022/23 | 2021/22 | 2020/21 | 2019/20 |
---|---|---|---|---|---|
AUDIT OUTCOME | Qualified | Qualified | Financially Unqualified | Financially Unqualified | Financially Unqualified |
FINANCIAL POSITION | |||||
Current Assets | 553 775 | 478 241 | 426 615 | 425 479 | 430 791 |
Non-Current Assets | 385 597 | 388 615 | 343 344 | 351 727 | 343 489 |
Total Assets | 939 372 | 866 856 | 769 959 | 777 206 | 774 281 |
Current Liabilities | 119 675 | 91 693 | 34 258 | 34 505 | 23 071 |
Non-Current Liabilities | 453 145 | 454 565 | 456 420 | 468 777 | 478 739 |
Total Liabilities | 572 820 | 546 259 | 490 678 | 503 282 | 501 810 |
Total Net Assets | 366 552 | 320 596 | 279 281 | 273 924 | 272 471 |
FINANCIAL PERFORMANCE | |||||
Total Revenue | 291 514 | 258 836 | 208 667 | 253 692 | 220 575 |
Revenue from Exchange Transactions | n/a | n/a | n/a | n/a | n/a |
Revenue from Non-Exchange Transactions | n/a | n/a | n/a | n/a | n/a |
Total Expenditure | (248 772) | (227 167) | (203 310) | (252 239) | (221 759) |
Employee Related costs | (90 818) | (87 191) | (92 501) | (92 426) | (88 409) |
Surplus/(Deficit) for Year | 42 742 | 31 669 | 5 357 | 1 453 | (1 184) |
CASH FLOW | Net Cash Flows from Operating Activities | 98 652 | 109 131 | 41 019 | 6 693 | (11 462) | Net Cash Flows from Investing Activities | (13 486) | (44 393) | (6 358) | (18 469) | (94 286) | Cash & Cash Equivalents at End of Year | 458 531 | 373 371 | 308 778 | 274 289 | 286 239 |
UIFW EXPENDITURE | |||||
Unauthorised Expenditure | - | - | - | - | - |
Irregular Expenditure | 3 152 694 | - | 424 | 9 400 | 1 999 |
Fruitless & Wasteful Expenditure | - | 8 | - | 4 948 | 7 425 |
HUMAN RESOURCES | |||||
Posts Approved | 265 | 278 | 278 | 277 | 274 |
Posts Filled | 174 | 196 | 196 | 205 | 209 |
SOURCE | Annual Report | Annual Report | Annual Report | Annual Report | Annual Report |
The information in this directory is compiled from various sources and is subject to continual change. If you notice any errors or omissions, contact us so that we may correct them.
ADVERTISEMENT
ADVERTISEMENT